Market Overview

EKO International Corp - October 2012 Sales Report


BURLINGTON, ON, Nov. 5, 2012 /PRNewswire/ - EKO INTERNATIONAL INC. (the "Company") -(EKNL- Pinksheets) is pleased to announce that NeuroVasc Clinical Inc. reports initial sales of $186,000 for the month of October 2012. Sales included FREMS equipment, NC-stat DPN Check devices and supplies.

Although a minor portion of October sales resulted from attendance at the Canadian Federation of Podiatric Medicine Conference in London, Ontario on October 26th and 27th, 2012, the Company is optimistic that the interest demonstrated in its products by health professionals will result in increased monthly sales volumes for the balance of this quarter.

This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. Actual events could differ materially and substantially from those projected herein and depend on a number of factors. Certain statements in this release, and other written or oral statements made by EKO International ("The Company") are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company's expectations include, but are not limited to, those factors that are disclosed under the heading "Risk Factors" and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities.


View Comments and Join the Discussion!

Partner Center